Literature DB >> 26756848

A model for predicting individuals' absolute risk of esophageal adenocarcinoma: Moving toward tailored screening and prevention.

Shao-Hua Xie1, Jesper Lagergren1,2.   

Abstract

Esophageal adenocarcinoma (EAC) is characterized by rapidly increasing incidence and poor prognosis, stressing the need for preventive and early detection strategies. We used data from a nationwide population-based case-control study, which included 189 incident cases of EAC and 820 age- and sex-matched control participants, from 1995 through 1997 in Sweden. We developed risk prediction models based on unconditional logistic regression. Candidate predictors included established and readily identifiable risk factors for EAC. The performance of model was assessed by the area under receiver operating characteristic curve (AUC) with cross-validation. The final model could explain 94% of all case patients with EAC (94% population attributable risk) and included terms for gastro-esophageal reflux symptoms or use of antireflux medication, body mass index (BMI), tobacco smoking, duration of living with a partner, previous diagnoses of esophagitis and diaphragmatic hernia and previous surgery for esophagitis, diaphragmatic hernia or severe reflux or gastric or duodenal ulcer. The AUC was 0.84 (95% confidence interval [CI] 0.81-0.87) and slightly lower after cross-validation. A simpler model, based only on reflux symptoms or use of antireflux medication, BMI and tobacco smoking could explain 91% of the case patients with EAC and had an AUC of 0.82 (95% CI 0.78-0.85). These EAC prediction models showed good discriminative accuracy, but need to be validated in other populations. These models have the potential for future use in identifying individuals with high absolute risk of EAC in the population, who may be considered for endoscopic screening and targeted prevention.
© 2016 UICC.

Entities:  

Keywords:  absolute risk; esophageal adenocarcinoma; prediction model; risk prediction

Mesh:

Year:  2016        PMID: 26756848     DOI: 10.1002/ijc.29988

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett's esophagus, and high-grade dysplasia/esophageal adenocarcinoma.

Authors:  Matthew F Buas; Haiwei Gu; Danijel Djukovic; Jiangjiang Zhu; Lynn Onstad; Brian J Reid; Daniel Raftery; Thomas L Vaughan
Journal:  Metabolomics       Date:  2017-01-20       Impact factor: 4.290

2.  Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma.

Authors:  Tariq A Hammad; Aaron P Thrift; Hashem B El-Serag; Nisreen S Husain
Journal:  Dig Dis Sci       Date:  2018-10-28       Impact factor: 3.199

3.  Use of the Electronic Health Record to Target Patients for Non-endoscopic Barrett's Esophagus Screening.

Authors:  Brittany L Baldwin-Hunter; Rita M Knotts; Samantha D Leeds; Joel H Rubenstein; Charles J Lightdale; Julian A Abrams
Journal:  Dig Dis Sci       Date:  2019-07-04       Impact factor: 3.199

4.  Inclusion of a gene-environment interaction between alcohol consumption and the aldehyde dehydrogenase 2 genotype in a risk prediction model for upper aerodigestive tract cancer in Japanese men.

Authors:  Motoki Iwasaki; Sanjeev Budhathoki; Taiki Yamaji; Sachiko Tanaka-Mizuno; Aya Kuchiba; Norie Sawada; Atsushi Goto; Taichi Shimazu; Manami Inoue; Shoichiro Tsugane
Journal:  Cancer Sci       Date:  2020-08-04       Impact factor: 6.716

5.  Development and Validation of an Esophageal Squamous Cell Carcinoma Risk Prediction Model for Rural Chinese: Multicenter Cohort Study.

Authors:  Junming Han; Lijie Wang; Huan Zhang; Siqi Ma; Yan Li; Zhongli Wang; Gaopei Zhu; Deli Zhao; Jialin Wang; Fuzhong Xue
Journal:  Front Oncol       Date:  2021-08-30       Impact factor: 6.244

6.  Risk prediction models for esophageal cancer: A systematic review and critical appraisal.

Authors:  He Li; Dianqin Sun; Maomao Cao; Siyi He; Yadi Zheng; Xinyang Yu; Zheng Wu; Lin Lei; Ji Peng; Jiang Li; Ni Li; Wanqing Chen
Journal:  Cancer Med       Date:  2021-08-20       Impact factor: 4.452

7.  Risk Prediction Model for Esophageal Cancer Among General Population: A Systematic Review.

Authors:  Ru Chen; Rongshou Zheng; Jiachen Zhou; Minjuan Li; Dantong Shao; Xinqing Li; Shengfeng Wang; Wenqiang Wei
Journal:  Front Public Health       Date:  2021-12-01

8.  Cause of death in patients diagnosed with esophageal cancer in Sweden: a population-based study.

Authors:  Shao-Hua Xie; Karl Wahlin; Jesper Lagergren
Journal:  Oncotarget       Date:  2017-02-11

9.  Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.

Authors:  Jing Dong; Matthew F Buas; Puya Gharahkhani; Bradley J Kendall; Lynn Onstad; Shanshan Zhao; Lesley A Anderson; Anna H Wu; Weimin Ye; Nigel C Bird; Leslie Bernstein; Wong-Ho Chow; Marilie D Gammon; Geoffrey Liu; Carlos Caldas; Paul D Pharoah; Harvey A Risch; Prasad G Iyer; Brian J Reid; Laura J Hardie; Jesper Lagergren; Nicholas J Shaheen; Douglas A Corley; Rebecca C Fitzgerald; David C Whiteman; Thomas L Vaughan; Aaron P Thrift
Journal:  Gastroenterology       Date:  2017-12-13       Impact factor: 22.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.